Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease.

Khor SP, Hsu A.

Curr Clin Pharmacol. 2007 Sep;2(3):234-43. Review.

PMID:
18690870
2.

Inhibition of cytosolic phospholipase A2alpha: hit to lead optimization.

McKew JC, Foley MA, Thakker P, Behnke ML, Lovering FE, Sum FW, Tam S, Wu K, Shen MW, Zhang W, Gonzalez M, Liu S, Mahadevan A, Sard H, Khor SP, Clark JD.

J Med Chem. 2006 Jan 12;49(1):135-58.

PMID:
16392799
3.
4.

Intratracheal administration of recombinant human factor IX (BeneFix) achieves therapeutic levels in hemophilia B dogs.

Russell KE, Read MS, Bellinger DA, Leitermann K, Rup BJ, McCarthy KP, Keith JC Jr, Khor SP, Schaub RG, Nichols TC.

Thromb Haemost. 2001 Mar;85(3):445-9.

PMID:
11307812
5.

In vivo absorption properties of orally administered recombinant human interleukin-11.

Tseng CM, Albert L, Peterson RL, Bouchard P, Dorner AJ, Keith J Jr, Khor SP.

Pharm Res. 2000 Apr;17(4):482-5. No abstract available.

PMID:
10870996
6.

Pharmacokinetics, pharmacodynamics, allometry, and dose selection of rPSGL-Ig for phase I trial.

Khor SP, McCarthy K, DuPont M, Murray K, Timony G.

J Pharmacol Exp Ther. 2000 May;293(2):618-24.

PMID:
10773036
7.

Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil.

Baker SD, Diasio RB, O'Reilly S, Lucas VS, Khor SP, Sartorius SE, Donehower RC, Grochow LB, Spector T, Hohneker JA, Rowinsky EK.

J Clin Oncol. 2000 Feb;18(4):915-26.

PMID:
10673535
8.

A modified equilibrium dialysis technique for measuring plasma protein binding: experimental evaluation with diazepam and nortriptyline.

Chow HH, Khor SP, Lee HC, Mayersohn M.

Pharm Res. 1998 Oct;15(10):1643-6. No abstract available.

PMID:
9794511
9.

Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer.

Schilsky RL, Hohneker J, Ratain MJ, Janisch L, Smetzer L, Lucas VS, Khor SP, Diasio R, Von Hoff DD, Burris HA 3rd.

J Clin Oncol. 1998 Apr;16(4):1450-7.

PMID:
9552051
10.

Pharmacokinetics of RheothRx injection in healthy male volunteers.

Jewell RC, Khor SP, Kisor DF, LaCroix KA, Wargin WA.

J Pharm Sci. 1997 Jul;86(7):808-12.

PMID:
9232521
11.
12.

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase.

Baker SD, Khor SP, Adjei AA, Doucette M, Spector T, Donehower RC, Grochow LB, Sartorius SE, Noe DA, Hohneker JA, Rowinsky EK.

J Clin Oncol. 1996 Dec;14(12):3085-96.

PMID:
8955653
13.

Supplemental Content

Support Center